Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Nervi

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Oncogene|March 1, 2005
Molecular signature of retinoic acid treatment in acute promyelocytic leukemiaNatalia Meani, Simone Minardi, Silvia Licciulli, et al.
Nature Medicine|December 28, 2004
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathwayAlessandra Insinga, Silvia Monestiroli, Simona Ronzoni, et al.
Blood|August 21, 2004
Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptorsSylvie Côté, Suzan McNamara, Daria Brambilla, et al.
Molecular and Cellular Biology|July 23, 2008
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marksLluis Morey, Carmen Brenner, Francesco Fazi, et al.
Nature Cell Biology|June 13, 2006
Myc-binding-site recognition in the human genome is determined by chromatin contextErnesto Guccione, Francesca Martinato, Giacomo Finocchiaro, et al.
Molecular Aspects of Medicine|December 30, 2014
Retinoic acid receptors: from molecular mechanisms to cancer therapyAlessandra di Masi, Loris Leboffe, Elisabetta De Marinis, et al.
Experimental Hematology & Oncology|January 24, 2024
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemiaWei Zhou, Siying Li, Hong Wang, et al.
Cancer Research|July 19, 2005
The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalphaElena Puccetti, Xiaomin Zheng, Daria Brambilla, et al.
Oncogene|May 16, 2003
Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiationRosamaria Mangiacasale, Carmine Pittoggi, Ilaria Sciamanna, et al.
Oncogene|February 3, 2005
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivoFrancesco Fazi, Lorena Travaglini, Daniela Carotti, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Oncogene|March 1, 2005
Molecular signature of retinoic acid treatment in acute promyelocytic leukemiaNatalia Meani, Simone Minardi, Silvia Licciulli, et al.
Nature Medicine|December 28, 2004
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathwayAlessandra Insinga, Silvia Monestiroli, Simona Ronzoni, et al.
Blood|August 21, 2004
Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptorsSylvie Côté, Suzan McNamara, Daria Brambilla, et al.
Molecular and Cellular Biology|July 23, 2008
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marksLluis Morey, Carmen Brenner, Francesco Fazi, et al.
Nature Cell Biology|June 13, 2006
Myc-binding-site recognition in the human genome is determined by chromatin contextErnesto Guccione, Francesca Martinato, Giacomo Finocchiaro, et al.
Molecular Aspects of Medicine|December 30, 2014
Retinoic acid receptors: from molecular mechanisms to cancer therapyAlessandra di Masi, Loris Leboffe, Elisabetta De Marinis, et al.
Experimental Hematology & Oncology|January 24, 2024
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemiaWei Zhou, Siying Li, Hong Wang, et al.
Cancer Research|July 19, 2005
The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalphaElena Puccetti, Xiaomin Zheng, Daria Brambilla, et al.
Oncogene|May 16, 2003
Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiationRosamaria Mangiacasale, Carmine Pittoggi, Ilaria Sciamanna, et al.
Oncogene|February 3, 2005
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivoFrancesco Fazi, Lorena Travaglini, Daniela Carotti, et al.
Pageof 6